Scavenger receptor class B, type I (SR-BI) facilitates selective uptake of cholesteryl ester (CE) from lipoprotein particles such as high-density lipoprotein (HDL) by a process in which HDL core-CE is taken into cells without a parallel uptake and degradation of the HDL particle itself. This SR-BI-mediated 'selective'pathway represents a major route for the delivery of CEs to the liver and steroidogenic tissues of rodents and humans for the biosynthesis of bile acids and steroid hormones, respectively. Besides facilitating selective CE transport, SR-BI also promotes reverse cholesterol transport (RCT) and exerts atheroprotective actions. Although much is known about these various functions of SR-BI, the cellular mechanisms controlling functional expression of SR-BI are not fully established. The overall goal of this competitive renewal application is to elucidate mechanisms by which certain positive and negative modulators regulate the expression and function of SR-BI in the liver, adrenal and gonads. Specifically, we propose to determine the stimulatory and inhibitory actions of SF-1/LRH-1 and NHERF1/2 and SIK-1 on SR-BI expression, SR-BI mediated selective CE transport and bile acid and steroid synthesis in liver and steroidogenic tissues.
The specific aims of the proposal are to: 1) characterize and establish the roles of LRH-1 and SF-1 in hormone-induced SR-BI expression and function in intact hepatic and steroidogenic tissues and isolated cells;2) determine how NHERF1 and NHERF2 potentially impact SR-BI expression, its cellular localization and SR-BI-mediated selective HDL-CE uptake in vitro and in vivo using hepatic and steroidogenic cells and genetic mouse models;and 3) identify underlying mechanisms by which SIK-1 inhibits SR-BI-dependent selective HDL-CE uptake in vivo and in hepatic and steroidogenic cell model systems in vitro. This proposal utilizes state-of-the-art molecular, cellular and biochemical and biophysical approaches and unique cell and animal models to dissect the molecular events mediating the modulatory actions of nuclear receptors SF-1 and LRH-1, PDZ-domain containing proteins NHERF1/2 and hormone-regulated SIK-1 protein. Successful completion of the proposed studies is likely to identify novel targets that can be exploited for the development of new therapies to treat bile acids and steroid hormone related diseases. On a broader scope, since SR-BI is atheroprotective, the current studies may also aid in the development of new therapeutic and preventive strategies in the clinical management of cardiovascular disease.

Public Health Relevance

Bile acids and steroid hormones are chemicals produced by the liver and adrenal/gonads, respectively, and are essential for a multitude of normal physiological processes. Bile acids play essential roles in facilitating lipid digestion and absorption, and also serve as important regulators of hepatic and intestinal function. Likewise, adrenal steroids influence carbohydrate, lipid, and protein metabolism, and salt and water balance, as well as inflammation, immunity and blood pressure, whereas gonadal steroids are critical for secondary sex characteristics, reproduction and muscle and bone growth. Both bile acids and steroids are synthesized from SR-BI-mediated selectively delivered cholesterol, thus underscoring the relevance of understanding the cellular mechanisms controlling the functional expression of SR-BI.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Liu, Lijuan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Palo Alto Institute for Research & Edu, Inc.
Palo Alto
United States
Zip Code
Khor, Victor K; Ahrends, Robert; Lin, Ye et al. (2014) The proteome of cholesteryl-ester-enriched versus triacylglycerol-enriched lipid droplets. PLoS One 9:e105047
Zaidi, Syed Kashif; Shen, Wen-Jun; Bittner, Stefanie et al. (2014) p38 MAPK regulates steroidogenesis through transcriptional repression of STAR gene. J Mol Endocrinol 53:1-16
Shen, Wen-Jun; Hu, Jie; Hu, Zhigang et al. (2014) Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions. Metabolism 63:875-86
Kraemer, Fredric B; Khor, Victor K; Shen, Wen-Jun et al. (2013) Cholesterol ester droplets and steroidogenesis. Mol Cell Endocrinol 371:15-9
Ueno, Masami; Shen, Wen-Jun; Patel, Shailja et al. (2013) Fat-specific protein 27 modulates nuclear factor of activated T cells 5 and the cellular response to stress. J Lipid Res 54:734-43
Shen, Wen-Jun; Zaidi, Syed Kashif; Patel, Shailja et al. (2012) Ablation of vimentin results in defective steroidogenesis. Endocrinology 153:3249-57
Chu, Victor C; Bhattacharya, Sayanti; Nomoto, Ann et al. (2011) Persistent expression of hepatitis C virus non-structural proteins leads to increased autophagy and mitochondrial injury in human hepatoma cells. PLoS One 6:e28551
Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun et al. (2011) Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI. Biochemistry 50:10860-75
Azhar, Salman (2010) Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiol 6:657-91
Bielicki, John K; Zhang, Haiyan; Cortez, Yuan et al. (2010) A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice. J Lipid Res 51:1496-503

Showing the most recent 10 out of 37 publications